Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia

被引：110

作者：

Castelli, Joel ^{[1
,2
,3
]}

Simon, Antoine ^{[2
,3
]}

Louvel, Guillaume ^{[1
]}

Henry, Olivier ^{[1
]}

Chajon, Enrique ^{[1
]}

Nassef, Mohamed ^{[2
,3
]}

Haigron, Pascal ^{[2
,3
]}

Cazoulat, Guillaume ^{[2
,3
]}

Ospina, Juan David ^{[2
,3
]}

Jegoux, Franck ^{[4
]}

Benezery, Karen ^{[5
]}

de Crevoisier, Renaud ^{[1
,2
,3
]}

机构：

[1] Ctr Eugene Marquis, Dept Radiotherapy, F-35000 Rennes, France

[2] Univ Rennes 1, LTSI, F-35000 Rennes, France

[3] INSERM, U1099, F-35000 Rennes, France

[4] CHU Pontchaillou, F-35000 Rennes, France

[5] Ctr Antoine Lacassagne, F-06100 Nice, France

来源：

RADIATION ONCOLOGY | 2015年 / 10卷

关键词：

Head and neck cancer; Anatomical variation; Adaptive RT; Xerostomia; INTENSITY-MODULATED RADIOTHERAPY; STAGE NASOPHARYNGEAL CARCINOMA; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; COMPLICATION PROBABILITY; VOLUME; IMRT; STRATEGIES; REGISTRATION;

D O I：

10.1186/s13014-014-0318-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Large anatomical variations occur during the course of intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNC). The risks are therefore a parotid glands (PG) overdose and a xerostomia increase. The purposes of the study were to estimate: - the PG overdose and the xerostomia risk increase during a "standard" IMRT (IMRTstd); - the benefits of an adaptive IMRT (ART) with weekly replanning to spare the PGs and limit the risk of xerostomia. Material and methods: Fifteen patients received radical IMRT (70 Gy) for LAHNC. Weekly CTs were used to estimate the dose distributions delivered during the treatment, corresponding either to the initial planning (IMRTstd) or to weekly replanning (ART). PGs dose were recalculated at the fraction, from the weekly CTs. PG cumulated doses were then estimated using deformable image registration. The following PG doses were compared: pre-treatment planned dose, per-treatment IMRTstd and ART. The corresponding estimated risks of xerostomia were also compared. Correlations between anatomical markers and dose differences were searched. Results: Compared to the initial planning, a PG overdose was observed during IMRTstd for 59% of the PGs, with an average increase of 3.7 Gy (10.0 Gy maximum) for the mean dose, and of 8.2% (23.9% maximum) for the risk of xerostomia. Compared to the initial planning, weekly replanning reduced the PG mean dose for all the patients (p < 0.05). In the overirradiated PG group, weekly replanning reduced the mean dose by 5.1 Gy (12.2 Gy maximum) and the absolute risk of xerostomia by 11% (p < 0.01) (30% maximum). The PG overdose and the dosimetric benefit of replanning increased with the tumor shrinkage and the neck thickness reduction (p < 0.001). Conclusion: During the course of LAHNC IMRT, around 60% of the PGs are overdosed of 4 Gy. Weekly replanning decreased the PG mean dose by 5 Gy, and therefore by 11% the xerostomia risk.

引用

页数：10

共 50 条

[1] Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia
Joel Castelli
Antoine Simon
Guillaume Louvel
Olivier Henry
Enrique Chajon
Mohamed Nassef
Pascal Haigron
Guillaume Cazoulat
Juan David Ospina
Franck Jegoux
Karen Benezery
Renaud de Crevoisier
[J]. Radiation Oncology, 10
[2] Optimal adaptive radiotherapy strategy in head and neck to spare the parotid glands
Castelli, J.
Zhang, P.
Simon, A.
Rigaud, B.
Arango, J. D. Ospina
Nassef, M.
Lafond, C.
Henry, O.
Haigron, P.
Li, B.
Shu, H.
De Crevoisier, R.
[J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S439 - S440
[3] Selection of head and neck cancer patients for adaptive radiotherapy to decrease xerostomia
Brouwer, Charlotte L.
Steenbakkers, Roel J. H. M.
van der Schaaf, Arjen
Sopacua, Chantal T. C.
van Dijk, Lisanne V.
Kierkels, Roel G. J.
Bijl, Hendrik P.
Burgerhof, Johannes G. M.
Langendijk, Johannes A.
Sijtsema, Nanna M.
[J]. RADIOTHERAPY AND ONCOLOGY, 2016, 120 (01) : 36 - 40
[4] Do we need adaptive radiotherapy in head and neck cancer to decrease xerostomia?
Castelli, J.
Simon, A.
Henry, O.
Chajon, E.
Nassef, M.
Louvel, G.
Cazoulat, G.
Jegoux, F.
Laguerre, B.
De Crevoisier, R.
[J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S226 - S226
[5] Impact of Weekly Replanning to Spare the Parotid Glands in Head and Neck Cancer Radiation Therapy
Castelli, J.
Simon, A.
Louvel, G.
Henry, O.
Chajon, E.
Nassef, M.
Haigron, P.
Cazoulat, G.
Ospina, J.
de Crevoisier, R.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S871 - S871
[6] Subregional analysis of the parotid glands: predicting late xerostomia in head and neck cancer
Berger, T.
Noble, D. J.
Shelley, L. E.
McMullan, T.
Romanchikova, M.
Carruthers, L. J.
Cebamanos, L.
Beckett, G.
Duffton, A.
Paterson, C.
Jena, R.
McLaren, D. B.
Burnet, N. G.
Nailon, W. H.
[J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S860 - S861
[7] Evaluation of Deformable Image Registration-Based Dose Accumulation for Parotid Glands in Head and Neck Adaptive Radiotherapy and its Impact on Prediction of Xerostomia
Gan, Y.
Langendijk, J. A.
Oldehinkel, E.
Lin, Z.
Both, S.
Brouwer, C. L.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E591 - E591
[8] Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients
Malouf, JG
Aragon, C
Henson, BS
Eisbruch, A
Ship, JA
[J]. CANCER DETECTION AND PREVENTION, 2003, 27 (04): : 305 - 310
[9] Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer
Rades, Dirk
Warwas, Britta
Cremers, Florian
Gerull, Karsten
Idel, Christian
Bruchhage, Karl L.
Hakim, Samer G.
Schild, Steven E.
[J]. ANTICANCER RESEARCH, 2022, 42 (07) : 3551 - 3556
[10] Predictors of Xerostomia after Head and Neck IMRT: Beyond the Parotid Glands
Little, M. B.
Feng, F. Y.
Vineberg, K.
Fritsch, B.
Murdoch-Kinch, C.
Eisbruch, A.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S81 - S81

← 1 2 3 4 5 →